Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CERS
#3124
Cerus Corp
2.0
1
USD
+4.69%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+4.69%
Monthly Change
+18.93%
6 month change
+25.62%
Year Change
+50.00%
Previous Close
1.9
2
Open
2.0
1
Bid
Ask
Low
2.0
1
High
2.0
1
Volume
36
Markets
US Stock Market
Healthcare
CERS
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
168.22 M
173.72 M
177.62 M
181.28 M
185.79 M
192.17 M
—
Valuation ratios
Enterprise value
1.19 B
1.22 B
716.89 M
476.72 M
364.7 M
473.6 M
1.56 B
Price to earnings ratio
-18.95
-21.45
-15.58
-10.29
-14
-25.75
-73.63
Price to sales ratio
9.93
7.31
3.51
2.08
1.41
1.68
-5 266.87
Price to cash flow ratio
-27.85
-34.39
-25.78
-9.02
25.02
81.17
237.88
Price to book ratio
10.93
13.78
9.77
7.4
5.06
6.11
9.82
Enterprise value to EBITDA ratio
-20.42
64.19
14.36
8.96
3.9
4.35
-1.25
Profitability ratios
Return on assets %
-0.27
-0.23
-0.2
-0.19
-0.1
-0.07
-0.07
Return on equity %
-0.58
-0.64
-0.62
-0.7
-0.37
-0.24
-0.27
Return on invested capital %
-500.85
-337.55
-158.07
-123.97
-68.14
-40.64
-50.88
Gross margin %
63.98
100
100
100
100
100
400
Operating margin %
-51.06
-30.68
-18.1
-16.09
-7.07
-3.71
-691.01
EBITDA margin %
-48.34
11.09
23.29
22.76
33.96
37.04
214.31 K
Net margin %
-52.39
-34.09
-22.72
-20.07
-10.39
-6.68
7 840.3
Liquidity ratios
Quick ratio
2.67
2.04
1.21
1.55
1.79
1.17
5.44
Current ratio
3.06
2.38
1.45
2.14
2.39
1.73
7.94
Inventory turnover
1.93
—
—
—
—
—
—
Asset turnover
0.59
0.7
0.83
0.9
1.01
1.11
-0.01
Solvency ratios
Debt to assets ratio
0.3
0.37
0.4
0.49
0.49
0.44
1.84
Debt to equity ratio
0.64
1.04
1.29
1.82
1.75
1.51
6.68
Long term debt to total assets ratio
0.22
0.29
0.32
0.4
0.42
0.38
1.58
Long term debt to total equity ratio
0.46
0.82
1.03
1.52
1.5
1.31
5.75
Per share metrics
Operating cash flow per share
-0.25
-0.2
-0.15
-0.24
0.06
0.03
0.03
EBIT per share
-0.36
0.08
0.23
0.22
0.36
0.45
-0.79
EBITDA per share
-0.34
0.1
0.25
0.24
0.37
0.45
-0.78
Total debt per share
0.41
0.51
0.49
0.53
0.53
0.51
2.07
Cash per share
0.81
0.76
0.58
0.37
0.44
0.43
1.68
Net current asset value per share
1.12
1.09
0.96
0.8
0.82
0.91
3.53
Tangible book value per share
0.64
0.49
0.38
0.28
0.3
0.33
1.22
Working capital per share
0.75
0.63
0.3
0.43
0.48
0.39
1.73
Book value per share
0.63
0.49
0.38
0.29
0.3
0.34
1.24
Cerus Corporation
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.
News
Jensen, Cerus Corp chief legal officer, sells $187k in stock
Cerus Corp COO Jayaraman sells $273k in shares
Cerus Corp CEO Greenman sells $742k in shares
Cerus Corp: chief medical officer Benjamin sells $168k in shares
Cerus Corp CFO green sells $211k in shares
Cerus names COO Vivek Jayaraman as next CEO effective July 1
Cerus CFO Kevin Green sells $169k in shares
Cerus corp chief medical officer sells shares worth $250k
Micron and MongoDB among market cap stock movers on Tuesday
Micron, Intel among market cap stock movers on Tuesday
Cerus earnings matched, revenue topped estimates
Cerus falls 7% after posting in-line Q4 earnings, revenue beat